Susan G. Komen addresses breast cancer on multiple fronts in order to make the biggest impact against this disease. Join our fight!
Breast Cancer: Web Sites You Can UseYvona FastVibrant Life
The USPSTF is also calling for more research to help close this important evidence gap. Some comments requested clarification of the patient population included in this recommendation, particularly as it relates to women with a family history of breast cancer or those with a genetic predisposition ...
Worldwide, breast cancer is the most frequently diagnosed life-threatening cancer in women. In less-developed countries, it is the leading cause of cancer death in women; in developed countries, however, it has been surpassed by lung cancer as a cause of
This guideline updates the American Cancer Society breast cancer screening recommendations for women at average risk for breast cancer.
And another large study is looking to find new breast cancer biomarkers by studying the blood, lymph nodes, and breast tissue of thousands of people who have had breast cancer. How to Participate in a Clinical Trial You can help doctors learn more about breast cancer and possibly get to try...
metastatic breast cancer and the importance of community medically reviewed by brunilda nazario,md on october 15, 2023 community is key when it comes to living well with metastatic breast cancer. strong social ties can help you feel less alone and more hopeful and in control of your future. ...
diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and evolving strategies for local and systemic therapy of breast cancer....
Systems-wide profiling of breast cancer has almost always entailed RNA and DNA analysis by microarray and sequencing techniques. Marked developments in proteomic technologies now enable very deep profiling of clinical samples, with high identification an
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures from tumors that represent the greatest unmet need: endocrine-resistant, treatment-refractory ...